Introducing rotavirus vaccine in eight sub-Saharan African countries: a cost-benefit analysis.

ABSTRACT:

Background

Stimulated by the economic challenges faced by many sub-Saharan African countries and the changes in the rotavirus burden across these countries, this study aimed to inform the decision of health policy makers of eight sub-Saharan countries, who are yet to introduce the rotavirus vaccine as of Dec 31, 2020, on the health economic consequences of the introduction of the vaccine in terms of the costs and benefits.

Methods

We did a cost-benefit analysis using a simulation-based decision-analytic model for children aged younger than 1 year, who were followed up to 259 weeks, in the Central African Republic, Chad, Comoros, Equatorial Guinea, Gabon, Guinea, Somalia, and South Sudan. Data were collected and analysed between Jan 13, 2020, and Dec 11, 2020. Cost-effectiven

SUBMITTER: Okafor CE 

PROVIDER: S-EPMC8315146 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature